SEARCH

SEARCH BY CITATION

References

  • Aird F., Clevenger C. V., Prystowsky M. B. and Redei E. (1993) Corticotropin-releasing factor mRNA in rat thymus and spleen. Proc. Natl Acad. Sci. USA 90, 71047108.
  • Armstrong R., Wen W., Meinkoth J., Taylor S. and Montminy M. (1995) A refractory phase in cyclic AMP-responsive transcription requires down regulation of protein kinase A. Mol. Cell Biol. 15, 18261832.
  • Benhar M., Dalyot I., Engelberg D. and Levitzki A. (2001) Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell Biol. 21, 69136926.
  • Brar B. K., Jonassen A. K., Stephanou A., Santilli G., Railson J., Knight R. A., Yellon D. M. and Latchman D. S. (2000) Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J. Biol. Chem. 275, 85088514.
  • Cejna M., Fritsch G., Printz D., Schulte-Hermann R. and Bursch W. (1994) Kinetics of apoptosis and secondary necrosis in cultured rat thymocytes and S.49 mouse lymphoma and CEM human leukemia cells. Biochem. Cell Biol. 72, 677685.
  • Chang C. P., Pearse R. V. II, O'Connell S. and Rosenfeld M. G. (1993) Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11, 11871195.
  • Chen W., Yu Y. L., Lee S. F., Chiang Y. J., Chao J. R., Huang J. H., Chiong J. H., Huang C. J., Lai M. Z., Yang-Yen H. F. et al. (2001) CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal. Mol. Cell Biol. 21, 46364646.
  • Dermitzaki E., Tsatsanis C., Gravanis A. and Margioris A. N. (2002) Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase. J. Biol. Chem. 277, 1228012287.
  • Elliott-Hunt C. R., Kazlauskaite J., Wilde G. J. C., Grammatopoulos D. K. and Hillhouse E. W. (2002) Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. J. Neurochem. 80, 416425.
  • Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., Elling F., Leist M. and Jaattela M. (2001) Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153, 9991010.
  • Fox M. W., Anderson R. E. and Meyer F. B. (1993) Neuroprotection by corticotropin releasing factor during hypoxia in rat brain. Stroke 24, 10721076.
  • Garcia-Calvo M., Peterson E. P., Leiting B., Ruel R., Nicholson D. W. and Thornberry N. A. (1998) Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273, 3260832613.
  • Grammatopoulos D., Dai Y., Chen J., Karteris E., Papadopoulou N., Easton A. J. and Hillhouse E. W. (1998) Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria. J. Clin. Endocrinol. Metab. 83, 25392544.
  • Harada H., Becknell B., Wilm M., Mann M., Huang L. J. S., Taylor S. S., Scott J. D. and Korsmeyer S. J. (1999) Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell 3, 413422.
  • Hauger R. L., Dautzenberg F. M., Flaccus A., Liepold T. and Spiess J. (1997) Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery. J. Neurochem. 68, 23082316.
  • Hengartner M. O. (2000) The biochemistry of apoptosis. Nature 407, 770776.
  • Hishita T., Tada-Oikawa S., Tohyama K., Miura Y., Nishihara T., Tohyama Y., Yoshida Y., Uchiyama T. and Kawanishi S. (2001) Caspase-3 activation by lysosomal enzymes in cytochrome c-independent apoptosis in myelodysplastic syndrome-derived cell line P39. Canc. Res. 61, 28782884.
  • Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J. L., Schneider P., Seed B. and Tschopp J. (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunol. 1, 489495.
  • Honig L. S. and Rosenberg R. N. (2000) Apoptosis and neurologic disease. Am. J. Med. 108, 317330.
  • Hsiang Y. H., Hertzberg R., Hecht S. and Liu L. F. (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260, 1487314878.
  • Hsu S. Y. and Hsueh A. J. (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nature Med. 7, 605611.
  • Ishisaka R., Kanno T., Akiyama J., Yoshioka T., Utsumi K. and Utsumi T. (2001) Activation of caspase-3 by lysosomal cysteine proteases and its role in 2,2′-azobis-(2-amidinopropane) dihydrochloride (AAPH)-induced apoptosis in HL-60 cells. J. Biochem. 129, 3541.
  • Janavs J. L., Pierce M. E. and Takahashi J. S. (1994) RNA synthesis inhibitors increase melatonin production in Y79 human retinoblastoma cells. Mol. Brain Res. 23, 4756.
  • Karteris E., Grammatopoulos D., Randeva H. and Hillhouse E. W. (2000) Signal transduction characteristics of the corticotropin-releasing hormone receptors in the feto-placental unit. J. Clin. Endocrinol. Metab. 85, 19891996.
  • Kawasaki H., Springett G. M., Mochizuki N., Toki S., Nakaya M., Matsuda M, Housman D. E. and Graybiel A. M. (1998) A family of cAMP-binding proteins that directly activate Rap1. Science 282, 22752279.
  • Kishimoto T., Radulovic J., Radulovic M., Lin C. R., Schrick C., Hooshmand F., Hermanson O., Rosenfeld M. G. and Spiess J. (2000) Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nature Genet. 24, 415419.
  • Lewis K., Li C., Perrin M. H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T. M., Gulyas J., Fischer W. et al. (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl Acad. Sci. USA 98, 75707575.
  • Lezoualc'h F., Engert S., Berning B. and Behl C. (2000) Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB. Mol. Endocrinol. 14, 147159.
  • Makrigiannakis A., Zoumakis E., Kalantaridou S., Coutifaris C., Margioris A. N., Coukos G., Rice K. C., Gravanis A. and Chrousos G. P. (2001) Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nature Immunol. 2, 10181024.
  • Mykles D. L. (2001) Proteinase families and their inhibitors. Meth. Cell Biol. 66, 247287.
  • Nicholson D. W. and Thornberry N. A. (1997) Caspases: killer proteases. Trends Biochem. Sci. 22, 299306.
  • Olianas M. C., Lampis G. and Onali P. (1995) Human Y-79 retinoblastoma cells exhibit specific corticotropin-releasing hormone binding sites. J. Neurochem. 64, 402407.
  • Park D. S., Morris E. J., Greene L. A. and Geller H. M. (1997) G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J. Neurosci. 17, 12561270.
  • Pedersen W. A., McCullers D., Culmsee C., Haughey N. J., Herman J. P. and Mattson M. P. (2001) Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol. Dis. 8, 492503.
  • Pedersen W. A., Wan R. Q., Zhang P. S. and Mattson M. P. (2002) Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J. Neurosci. 22, 404412.
  • Radulovic J., Sydow S. and Spiess J. (1998) Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. J. Neurosci. Res. 54, 507521.
  • Radulovic M., Dautzenberg F. M., Sydow S., Radulovic J. and Spiess J. (1999) Corticotropin-releasing factor receptor 1 in mouse spleen: expression after immune stimulation and identification of receptor-bearing cells. J. Immunol. 162, 30133021.
  • Rao R. V., Hermel E., Castro-Obregon S., Del Rio G., Ellerby L. M., Ellerby H. M. and Bredesen D. E. (2001) Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J. Biol. Chem. 276, 3386933874.
  • Reyes T. M., Lewis K., Perrin M. H., Kunitake K. S., Vaughan J., Arias C. A., Hogenesch J. B., Gulyas J., Rivier J. and Vale W. W. et al. (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl Acad. Sci. USA 98, 28432848.
  • Rolig R. L. and McKinnon P. J. (2000) Linking DNA damage and neurodegeneration. Trends Neurosci. 23, 417424.
  • Rothenberg M. L. (1997) Topoisomerase I inhibitors: review and update. Ann. Oncol. 8, 837855.
  • Rotonda J., Nicholson D. W., Fazil K. M., Gallant M., Gareau Y., Labelle M., Peterson E. P., Rasper D. M., Ruel R., Vaillancourt J. P. et al. (1996) The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nature Struct. Biol. 3, 619625.
  • Ruhmann A., Bonk I., Lin C. R., Rosenfeld M. G. and Spiess J. (1998) Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30. Proc. Natl Acad. Sci. USA 95, 1526415269.
  • Santoro B., Liu D. T., Yao H., Bartsch D., Kandel E. R., Siegelbaum S. A. and Tibbs G. R. (1998) Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell 93, 717729.
  • Slee E. A., Adrain C. and Martin S. J. (2001) Executioner caspase-3-6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276, 73207326.
  • Spiess J., Rivier J., Rivier C. and Vale W. (1981) Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc. Natl Acad. Sci. USA 78, 65176521.
  • Strasser A., O'Connor L. and Dixit V. M. (2000) Apoptosis signaling. Annu. Rev. Biochem. 69, 217245.
  • Theoharides T. C., Singh L. K., Boucher W., Pang X. Z., Letourneau R., Webster E. and Chrousos G. (1998) Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139, 403413.
  • Vaughan J., Donaldson C., Bittencourt J., Perrin M. H., Lewis K., Sutton S., Chan R., Turnbull A. V., Lovejoy D. and Rivier C. (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287292.
  • Vintermyr O. K., Boe R., Brustugun O. T., Maronde E., Aakvaag A. and Doskeland S. O. (1995) Cyclic adenosine monophosphate (cAMP) analogs 8-Cl- and 8-NH2-cAMP induce cell death independently of cAMP kinase-mediated inhibition of the G1/S transition in mammary carcinoma cells (MCF-7). Endocrinology 136, 25132520.
  • Walton M., Woodgate A. M., Muravlev A., Xu R., During M. J. and Dragunow M. (1999) CREB phosphorylation promotes nerve cell survival. J. Neurochem. 73, 18361842.
  • Webster E. L., Lewis D. B., Torpy D. J., Zachman E. K., Rice K. C. and Chrousos G. P. (1996) In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137, 57475750.
  • Van Der Werff ten Bosch J., Otten J. and Thielemans K. (2001) Autoimmune lymphoproliferative syndrome type III, an indefinite disorder. Leuk. Lymph. 41, 501511.
  • Wu J. T., Archer S. Y., Hinnebusch B., Meng S. and Hodin R. A. (2001) Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G482G490.
  • Zheng T. S. and Flavell R. A. (2000) Divinations and surprises: genetic analysis of caspase function in mice. Exp. Cell Res. 256, 6773.